Zobrazeno 1 - 10
of 26
pro vyhledávání: '"Madleen Chassang"'
Autor:
Clémence Bertold, Laura Troin, Madleen Chassang, Thierry Passeron, Jérôme Doyen, Henri Montaudié, Alexandra Picard‐Gauci
Publikováno v:
JEADV Clinical Practice, Vol 2, Iss 4, Pp 940-943 (2023)
Abstract Merkel cell carcinoma (MCC) is a rare and aggressive neuroendocrine skin cancer, associated with high mortality. Immune checkpoint inhibitors (ICIs) have demonstrated long‐lasting efficiency for treating advanced MCC. Despite a good safety
Externí odkaz:
https://doaj.org/article/244192f47e7e4833ab1c1440aa6f4cc5
Publikováno v:
JEADV Clinical Practice, Vol 1, Iss 2, Pp 129-131 (2022)
Abstract Background Merkel cell carcinoma (MCC) is a rare and aggressive cutaneous neuroendocrine malignancy. Immune checkpoint inhibitors (ICIs) have transformed the treatment landscape for patients with metastatic MCC (mMCC). In mMCC, the response
Externí odkaz:
https://doaj.org/article/edcacaa87e3043dcbf2642351ca2e95e
Autor:
Sébastien Frey, Lidia Santarpia, Madleen Chassang, Anne-Sophie Schneck, Rodolphe Anty, Jean Gugenheim, Antonio Iannelli
Publikováno v:
Transplantation Reports, Vol 5, Iss 4, Pp 100067- (2020)
Today, bariatric surgery has become the main therapeutic means to fight against the escalating increase in obesity, worldwide. Besides that, non-alcoholic steatohepatitis has inflated its indication for liver transplantation. Liver transplant surgeon
Externí odkaz:
https://doaj.org/article/bc06efbab7224945b4e9d3f8d14481ec
Publikováno v:
Journal d'imagerie diagnostique et interventionnelle.
Publikováno v:
Revue du Rhumatisme. 87:307-309
Autor:
Anne-Sophie Schneck, Lidia Santarpia, Sébastien Frey, Antonio Iannelli, Madleen Chassang, Jean Gugenheim, Rodolphe Anty
Publikováno v:
Transplantation Reports, Vol 5, Iss 4, Pp 100067-(2020)
Today, bariatric surgery has become the main therapeutic means to fight against the escalating increase in obesity, worldwide. Besides that, non-alcoholic steatohepatitis has inflated its indication for liver transplantation. Liver transplant surgeon
Autor:
Patrick Chevallier, Imene Fatfouta, Manuelle Volondat, Eric Fontas, Jérôme Delotte, Madleen Chassang
Publikováno v:
European Radiology. 29:501-508
To compare diagnostic accuracy of MR-hysterosalpingography (MR-HSG) and conventional hysterosalpingography (X-HSG) in the evaluation of female infertility. Forty women received prospectively both X-HSG, the gold standard technique, and MR-HSG on the
Autor:
Patrick Chevallier, Madleen Chassang, Guillaume Baudin, Manuelle Volondat, Jérôme Delotte, Anne Chevallier
Publikováno v:
Imagerie de la Femme. 27:234-237
Resume Les cancers primitifs tubaires sont rares et de diagnostic difficile en imagerie. Nous presentons le cas d’une patiente de 51 ans, chez qui a ete decouvert un carcinome tubaire primitif metastatique dans le cadre du suivi en imagerie de sa m
Autor:
Jean-Baptiste Delhorme, Jordan Ohayon, Sébastien Gouy, Gerlinde Averous, Catherine Genestie, Léopold Gaichies, Olivier Glehen, Jean-Marc Guilloit, Denis Pezet, Francois Quenet, Gwenaël Ferron, Cécile Brigand, Philippe Morice, Charles Honoré, Julio Abba, Karine Abboud, Mohammad Alyami, Catherine Arvieux, Naoual Bakrin, Gisèle Balagué, Vincent Barrau, Houda Ben Rejeb, Jean-Marc Bereder, Isabelle Berton-Rigaud, Frédéric Bibeau, Isabelle Bonnefoy, Dominique Bouzard, Ivan Bricault, Sébastien Carrère, Cécile de Chaisemartin, Madleen Chassang, Anne Chevallier, Thomas Courvoisier, Peggy Dartigues, Anthony Dohan, Julien Dubreuil, Frédéric Dumont, Clarisse Eveno, Marie Faruch-Bilfeld, Juliette Fontaine, Laure Fournier, Johan Gagniere, Delphine Geffroy, Laurent Ghouti, François-Noël Gilly, Laurence Gladieff, Diane Goéré, Aymeric Guibal, Frédéric Guyon, Bruno Heyd, Christine Hoeffel, Constance Hordonneau, Sylvie Isaac, Peggy Jourdan-Enfer, Rachid Kaci, Reza Kianmanesh, Catherine Labbé-Devilliers, Joëlle Lacroix, Bernard Lelong, Agnès Leroux-Broussier, Yoann Lherm, Réa Lo Dico, Gérard Lorimier, Caroline Malhaire, Frédéric Marchal, Pascale Mariani, Emilie Mathiotte, Pierre Meeus, Eliane Mery, Simon Msika, Cédric Nadeau, Pablo Ortega-Deballon, Guillaume Passot, Olivier Pellet, Patrice Peyrat, Nicolas Pirro, Marc Pocard, Flora Poizat, Jack Porcheron, Anaïs Poulet, François Quenet, Patrick Rat, Pierre Rousselot, Pascal Rousset, Hélène Senellart, Martine Serrano, Vincent Servois, Olivia Sgabura, Andrea Skanjeti, Magali Svrcek, Raphaël Tetreau, Emilie Thibaudeau, Yann Touchefeu, Jean-Jacques Tuech, Séverine Valmary-Degano, Delphine Vaudoyer, Stéphane Velasco, Véronique Verriele-Beurrier, Laurent Villeneuve, Romuald Wernert, Franck Zinzindohoue
Publikováno v:
EJSO-European Journal of Surgical Oncology
EJSO-European Journal of Surgical Oncology, 2020, 46 (5), pp.862-867. ⟨10.1016/j.ejso.2019.12.005⟩
EJSO-European Journal of Surgical Oncology, WB Saunders, 2020, 46 (5), pp.862-867. ⟨10.1016/j.ejso.2019.12.005⟩
EJSO-European Journal of Surgical Oncology, 2020, 46 (5), pp.862-867. ⟨10.1016/j.ejso.2019.12.005⟩
EJSO-European Journal of Surgical Oncology, WB Saunders, 2020, 46 (5), pp.862-867. ⟨10.1016/j.ejso.2019.12.005⟩
International audience; Purpose: Psammocarcinoma (PK) is a rare disease of unknown origin. We aimed to report the characteristics, management and survival of patients operated on for PK within the French Network for Rare Peritoneal Malignancies (RENA
Autor:
Benoît Audelan, Henri Montaudié, Jonathan Benzaquen, Simon Heeke, Hervé Delingette, Charles-Hugo Marquette, Olivier Bordone, Marius Ilie, Salomé Lalvée, Michel Poudenx, Elodie Long-Mira, Véronique Hofman, Albrecht Stenzinger, Olivier Humbert, Pierre-Michel Dugourd, Katia Zahaf, Thierry Passeron, Paul Hofman, Madleen Chassang, Virginie Lespinet
Publikováno v:
Cancers
Cancers, MDPI, 2019, 11, ⟨10.3390/cancers11091271⟩
Cancers, 2019, 11, ⟨10.3390/cancers11091271⟩
Cancers, Vol 11, Iss 9, p 1271 (2019)
Volume 11
Issue 9
Cancers, MDPI, 2019, 11, ⟨10.3390/cancers11091271⟩
Cancers, 2019, 11, ⟨10.3390/cancers11091271⟩
Cancers, Vol 11, Iss 9, p 1271 (2019)
Volume 11
Issue 9
Tumor mutational burden (TMB) has emerged as an important potential biomarker for prediction of response to immune-checkpoint inhibitors (ICIs), notably in non-small cell lung cancer (NSCLC). However, its in-house assessment in routine clinical pract
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::903688775d3f66d2a7e9b7c407f5e895
https://hal.inria.fr/hal-02381188
https://hal.inria.fr/hal-02381188